Literature DB >> 21224039

Insulin-like growth factor system and sporadic malignant melanoma.

Ettore Capoluongo1.   

Abstract

Insulin and insulin-like growth factors (IGFs) are important regulators of energy metabolism and growth. Several findings have outlined an important role played by this family of molecules in both tumor maintenance and development. Despite the established contribution of the IGF system in carcinogenesis, little and contrasting data have been reported concerning the intertwined relationships between melanoma and this family of molecules. The present minireview aims to summarize the main topics and evidence concerning this malignant skin cancer, with a focus on the following: i) melanoma and cell proliferation effects induced by the IGF system, ii) in vitro and in vivo experimental data, and iii) targeting studies. Because of consistent findings regarding the role of the IGF-1 receptor in the modulation of IGF-1 activity, possible therapeutic strategies combining the use of antisense oligonucleotides against IGF-1 receptor mRNA could be applied in the future. Copyright Â
© 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21224039      PMCID: PMC3069928          DOI: 10.1016/j.ajpath.2010.11.004

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  60 in total

Review 1.  Cellular actions of the insulin-like growth factor binding proteins.

Authors:  Sue M Firth; Robert C Baxter
Journal:  Endocr Rev       Date:  2002-12       Impact factor: 19.871

2.  Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators.

Authors:  C Deal; J Ma; F Wilkin; J Paquette; F Rozen; B Ge; T Hudson; M Stampfer; M Pollak
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

Review 3.  Defining the pathway to insulin-like growth factor system targeting in cancer.

Authors:  Steven A Rosenzweig; Hanudatta S Atreya
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

Review 4.  Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction.

Authors:  J Dupont; D LeRoith
Journal:  Horm Res       Date:  2001

5.  Overexpression of the acid-labile subunit of the IGF ternary complex in transgenic mice.

Authors:  J V Silha; Y Gui; T Modric; A Suwanichkul; S K Durham; D R Powell; L J Murphy
Journal:  Endocrinology       Date:  2001-10       Impact factor: 4.736

Review 6.  Insulin-like growth factor 1 (IGF-1): a growth hormone.

Authors:  Z Laron
Journal:  Mol Pathol       Date:  2001-10

Review 7.  Malignant melanoma: prevention, early detection, and treatment in the 21st century.

Authors:  D S Rigel; J A Carucci
Journal:  CA Cancer J Clin       Date:  2000 Jul-Aug       Impact factor: 508.702

8.  Insulin-like growth factor-I-induced migration of melanoma cells is mediated by interleukin-8 induction.

Authors:  Kapaettu Satyamoorthy; Gang Li; Bhavesh Vaidya; Jiri Kalabis; Meenhard Herlyn
Journal:  Cell Growth Differ       Date:  2002-02

9.  BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.

Authors:  Jianli Dong; Robert G Phelps; Rui Qiao; Shen Yao; Outhiriaradjou Benard; Zeev Ronai; Stuart A Aaronson
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

10.  Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk.

Authors:  Eva S Schernhammer; Susan E Hankinson; David J Hunter; Marie J Blouin; Michael N Pollak
Journal:  Int J Cancer       Date:  2003-10-20       Impact factor: 7.396

View more
  16 in total

1.  Response to "Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?".

Authors:  Yibing Ruan; Aru Narendran
Journal:  Neuro Oncol       Date:  2016-01       Impact factor: 12.300

2.  A crayfish insulin-like-binding protein: another piece in the androgenic gland insulin-like hormone puzzle is revealed.

Authors:  Ohad Rosen; Simy Weil; Rivka Manor; Ziv Roth; Isam Khalaila; Amir Sagi
Journal:  J Biol Chem       Date:  2013-06-17       Impact factor: 5.157

3.  Association Between Melanoma Risk and Height: A Narrative Review.

Authors:  Gino A Vena; Nicoletta Cassano; Stefano Caccavale; Giuseppe Argenziano
Journal:  Dermatol Pract Concept       Date:  2019-04-30

4.  The Potent Humanin Analogue (HNG) Protects Germ Cells and Leucocytes While Enhancing Chemotherapy-Induced Suppression of Cancer Metastases in Male Mice.

Authors:  YanHe Lue; Ronald Swerdloff; Junxiang Wan; Jialin Xiao; Samuel French; Vince Atienza; Victor Canela; Kevin W Bruhn; Brian Stone; Yue Jia; Pinchas Cohen; Christina Wang
Journal:  Endocrinology       Date:  2015-09-18       Impact factor: 4.736

5.  Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.

Authors:  Liron Zehavi; Roi Avraham; Aviv Barzilai; Dalia Bar-Ilan; Roy Navon; Yechezkel Sidi; Dror Avni; Raya Leibowitz-Amit
Journal:  Mol Cancer       Date:  2012-07-02       Impact factor: 27.401

6.  A Comparison of B16 Melanoma Cells and 3T3 Fibroblasts Concerning Cell Viability and ROS Production in the Presence of Melatonin, Tested Over a Wide Range of Concentrations.

Authors:  Maria Angeles Bonmati-Carrion; Nuria Alvarez-Sánchez; Rüdiger Hardeland; Juan Antonio Madrid; Maria Angeles Rol
Journal:  Int J Mol Sci       Date:  2013-02-14       Impact factor: 5.923

7.  Growth factors involve in cellular proliferation, differentiation and migration during prostate cancer metastasis.

Authors:  Ilaha Isali; Mohammed Adel Ali Al-Sadawi; Arshna Qureshi; Ahmad O Khalifa; Mukesh K Agrawal; Sanjeev Shukla
Journal:  Int J Cell Biol Physiol       Date:  2019-10-07

8.  Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways.

Authors:  Reetobrata Basu; Shiyong Wu; John J Kopchick
Journal:  Oncotarget       Date:  2017-03-28

Review 9.  Ursolic Acid-Regulated Energy Metabolism-Reliever or Propeller of Ultraviolet-Induced Oxidative Stress and DNA Damage?

Authors:  Yuan-Hao Lee; Youping Sun; Randolph D Glickman
Journal:  Proteomes       Date:  2014-08-06

10.  A novel antisense long noncoding RNA within the IGF1R gene locus is imprinted in hematopoietic malignancies.

Authors:  Jingnan Sun; Wei Li; Yunpeng Sun; Dehai Yu; Xue Wen; Hong Wang; Jiuwei Cui; Guanjun Wang; Andrew R Hoffman; Ji-Fan Hu
Journal:  Nucleic Acids Res       Date:  2014-08-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.